Ultima Vez Modificado: 15 de octubre del 2004
Conference Date: December 11, 2004
Conference Location: San Francisco, CA
Conference Date: January 8, 2005
Conference Location: Atlanta, GA
Conference Date: February 5, 2005
Conference Location: Philadelphia, PA
Conference Web Page URL: www.thecbce.com/futureprograms.asp
Topics Covered: This continuing medical education (CME) activity will compare the biology, clinical efficacy, and toxicity of small-molecule EGFR inhibitors in the treatment of NSCLC.
Who Should Attend: This activity is designed primarily for medical oncologists and other physicians interested in the treatment of cancer.
Continuing Education: Yes
May 3, 2012 - Adding chemotherapy with carboplatin plus paclitaxel to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib does not improve efficacy in the treatment of chemotherapy-naive, never or light former smokers with advanced non-small-cell lung cancer, according to a study published online April 30 in the Journal of Clinical Oncology.
Jul 7, 2011